Internal Medicine, Gastroenterology · Columbus, OH
NPI
1851685812
Since 2011
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
11
Medicare group memberships
Hospitals
2
Hospital affiliations
410 W 10th Ave
Columbus, OH, 43210
Phone (614) 293-6255
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
503 services
Medicare patients, 2024
282
Average age 70
Drug cost, 2024
$457K
1,141 prescriptions
Company payments, 2025
$15.93
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Subhankar Chakraborty was code 91010 (test - miscellaneous), 57 times for 56 patients. In total Subhankar Chakraborty billed 503 services in 36 codes, and Medicare paid $43K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 91010 Test - Miscellaneous | Facility | 57 | 56 | $45.96 | $2,620 |
| 91037 Test - Miscellaneous | Facility | 54 | 53 | $34.51 | $1,864 |
| 99215 Office E&M - Established | Office | 42 | 37 | $121.63 | $5,108 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 33 | 30 | $12.49 | $412 |
| 99223 Hospital E&M - Initial | Facility | 32 | 32 | $130.68 | $4,182 |
| 99214 Office E&M - Established | Office | 28 | 25 | $87.93 | $2,462 |
| 43239 Upper GI Endoscopy | Facility | 27 | 27 | $72.29 | $1,952 |
| 91010 Test - Miscellaneous | Office | 27 | 27 | $156.06 | $4,214 |
| 91037 Test - Miscellaneous | Office | 24 | 24 | $117.46 | $2,819 |
| 45385 Colonoscopy - Lesion Removal | Facility | 14 | 14 | $200.44 | $2,806 |
| 99204 Office E&M - New | Office | 13 | 13 | $111.22 | $1,446 |
| 99203 Office E&M - New | Office | 12 | 12 | $69.89 | $839 |
| 99232 Hospital E&M - Subsequent | Facility | 12 | 12 | $59.55 | $715 |
By year: 2022 $62K for 577 services; 2023 $52K for 504 services; 2024 $43K for 503 services.
Medicare prescription drug claims, 2024
In 2024, the drug Subhankar Chakraborty prescribed most often to Medicare patients was Pantoprazole Sodium, with 97 prescriptions and refills. In total Subhankar Chakraborty wrote 1,141 Medicare prescriptions that cost $457K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 97 | 164 | 23 | $2,842 |
| Famotidine Generic | 85 | 126 | 22 | $1,199 |
| Omeprazole Generic | 81 | 156 | 28 | $1,524 |
| Amitriptyline Hcl Generic | 70 | 141 | 18 | $1,076 |
| Lansoprazole Generic | 63 | 87 | 14 | $1,533 |
| Linzess Linaclotide | 56 | 72 | 20 | $45K |
| Aprepitant Generic | 50 | 58 | Under 11 | $259K |
| Promethazine Hcl Generic | 43 | 46 | 12 | $516 |
| Ondansetron Odt Ondansetron | 42 | 43 | 16 | $1,005 |
| Lactated Ringers Ringer's Solution,lactated | 38 | 38 | Under 11 | $2,004 |
| Erythromycin Erythromycin Base | 29 | 48 | Under 11 | $24K |
| Metoclopramide Hcl Generic | 26 | 26 | Under 11 | $163 |
| Ondansetron Hcl Ondansetron Hcl/Pf | 24 | 24 | Under 11 | $574 |
| Famotidine Famotidine/Pf | 24 | 24 | Under 11 | $88.8 |
| Motegrity Prucalopride Succinate | 23 | 33 | Under 11 | $23K |
Brand drugs: - claims; generic drugs: 941 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Subhankar Chakraborty $15.93 ($15.93 in general payments such as food, travel and fees) from 3 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $15.93.
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $15.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.